DBV Technologies S.A. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DBV Technologies S.A. on March 10, 2023. The registrant is a French biopharmaceutical company incorporated in France, with its principal executive offices in Montrouge, France. Its American Depositary Shares trade on The Nasdaq Stock Market LLC under the symbol DBVT.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report is a disclosure regarding the company's banking relationships rather than a financial results announcement.
Material Changes
There are no material changes to financial performance or operations reported in this document. The sole material disclosure addresses the company's exposure to Silicon Valley Bank.
Management Commentary and Risks
Under Item 7.01 (Regulation FD Disclosure), management explicitly stated that DBV Technologies S.A. does not hold cash deposits or securities at Silicon Valley Bank. This disclosure was made to clarify the company's liquidity position and risk exposure in the context of the banking sector instability occurring at the time of the filing.
Investor Verification Checklist
- Confirm the company has no deposits or securities held at Silicon Valley Bank.
- Verify the trading status of DBVT on The Nasdaq Stock Market LLC.
- Note that this filing is not deemed "filed" for purposes of Section 18 of the Exchange Act.